To Get Help Now
Click Here
 
Today's Date:

20,000 Avandia Lawsuits Settled

AddThis Social Bookmark Button

GlaxoSmithKline Plc has agreed to settle more than 20,000 lawsuits filed against the drug maker over allegations that the type 2 diabetes medication Avandia causes heart attacks. The agreement came during court ordered mediation.

U.S. District Judge Cynthia Rufe appointed Patrick A. Juneau as the Avandia mediator for the 2,500 cases consolidated to her court and gave the parties a 75-day deadline to resolve 85 percent of the cases. Bloomberg reports that it is unknown whether enough cases were settled before the deadline. If not, Judge Rufe will begin scheduling trials.

Glaxo is paying $3 billion to resolve U.S. criminal and civil investigations by the U.S. government that it illegally marketed at least nine medications, including Avandia. Last year, the UK-based drug manufacturer agreed to pay $700 million to settle over 15,000 patient filed lawsuits.

In 2010, Glaxo stopped promoting the drug after regulators pulled it from the European market, and limited sales in the United States after studies showed the drug increased the risk of heart attack.

Glaxo’s U.S. spokesperson Bernadette King wrote in an email to Bloomberg that the recent settlements of the cases “are covered by existing provisions and those payments will be funded through existing cash resources.”

Normal
0

false
false
false

MicrosoftInternetExplorer4

/* Style Definitions */
table.MsoNormalTable
{mso-style-name:”Table Normal”;
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-parent:””;
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-para-margin:0in;
mso-para-margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:10.0pt;
font-family:”Times New Roman”;
mso-ansi-language:#0400;
mso-fareast-language:#0400;
mso-bidi-language:#0400;}

GlaxoSmithKline Plc has agreed to settle more than 20,000 lawsuits filed against the drug maker over allegations that the type 2 diabetes medication Avandia causes heart attacks. The agreement came during court ordered mediation.

U.S. District Judge Cynthia Rufe appointed Patrick A. Juneau as the Avandia mediator for the 2,500 cases consolidated to her court and gave the parties a 75-day deadline to resolve 85 percent of the cases. Bloomberg reports that it is unknown whether enough cases were settled before the deadline. If not, Judge Rufe will begin scheduling trials.

Glaxo is paying $3 billion to resolve U.S. criminal and civil investigations by the U.S. government that it illegally marketed at least nine medications, including Avandia. Last year, the UK-based drug manufacturer agreed to pay $700 million to settle over 15,000 patient filed lawsuits.

In 2010, Glaxo stopped promoting the drug after regulators pulled it from the European market, and limited sales in the United States after studies showed the drug increased the risk of heart attack.

Glaxo’s U.S. spokesperson Bernadette King wrote in an email to Bloomberg that the recent settlements of the cases “are covered by existing provisions and those payments will be funded through existing cash resources.”

breakinglawsuitnews.com disclaimer: This article: 20,000 Avandia Lawsuits Settled was posted on Thursday, February 2nd, 2012 at 7:49 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Comments are closed.